Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
2.890
+0.060 (2.12%)
At close: Nov 20, 2024, 4:00 PM
2.810
-0.080 (-2.77%)
Pre-market: Nov 21, 2024, 7:41 AM EST
Vivos Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Vivos Therapeutics stock have an average target of 6.30, with a low estimate of 6.00 and a high estimate of 6.60. The average target predicts an increase of 117.99% from the current stock price of 2.89.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for VVOS stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Reiterates $6.6 | Strong Buy | Reiterates | $6.6 | +128.37% | Nov 20, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $8.25 → $6 | Strong Buy | Maintains | $8.25 → $6 | +107.61% | Nov 19, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6.4 → $6.6 | Strong Buy | Maintains | $6.4 → $6.6 | +128.37% | Aug 20, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $63 | Strong Buy | Initiates | $63 | +2,062.63% | Jan 17, 2023 |
| Roth Capital | Roth Capital | Strong Buy Maintains $275 → $250 | Strong Buy | Maintains | $275 → $250 | +8,550.52% | Aug 13, 2021 |
Financial Forecast
Revenue This Year
17.25M
from 13.80M
Increased by 24.99%
Revenue Next Year
24.65M
from 17.25M
Increased by 42.92%
EPS This Year
-2.60
from -11.14
EPS Next Year
-0.56
from -2.60
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | 17.8M | 25.4M |
| Avg | 17.3M | 24.7M |
| Low | 16.6M | 23.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | 28.7% | 47.1% |
| Avg | 25.0% | 42.9% |
| Low | 20.1% | 37.3% |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -2.68 | -0.58 |
| Avg | -2.60 | -0.56 |
| Low | -2.50 | -0.54 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.